Beryl Drugs Ltd
NSE: BSE: 524606
₹20.19
(-7.17%)
Sat, 07 Mar 2026, 02:43 am
Market Cap102.4M
PE Ratio721.07
Dividend0
Health Technology
Pharmaceuticals: Other
24.5KBeryl Drugs Income Statement
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 69.39M | 67.53M | 74.15M | 91.69M | 144.30M | 144.65M | 132.33M | 130.22M | 108.96M | 151.04M | 128.37M | 127.76M | 139.69M | 144.00M | 262.47M | 263.53M | 208.74M |
| Gross profit | 9.49M | 5.74M | 5.83M | 6.11M | 15.00M | 13.17M | 12.66M | 9.96M | 13.84M | 29.54M | 28.74M | 25.63M | 20.81M | 15.72M | 51.68M | 54.73M | 27.68M |
| Operating expenses (excl. COGS) | -8.19M | -3.86M | -5.28M | -4.19M | -8.64M | -8.68M | -10.45M | -8.91M | -18.27M | -22.26M | -21.49M | -22.92M | -18.82M | -22.26M | -40.17M | -43.81M | -27.81M |
| Selling/general/admin expenses, total | -8.24M | -3.37M | -4.87M | -3.71M | -7.91M | -8.33M | -10.08M | -8.02M | -18.18M | -21.87M | -21.26M | -22.81M | -18.78M | -21.97M | -39.67M | -43.00M | -27.75M |
| Research & development | 0 | 0 | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -8.24M | -3.37M | -4.87M | -3.71M | -7.91M | -8.33M | -10.08M | -8.02M | -18.18M | -21.87M | -21.26M | -22.81M | -18.78M | -21.97M | -39.67M | -43.00M | -27.75M |
| Other operating expenses, total | 53.28K | -490.45K | -410.04K | -485.97K | -721.60K | -344.22K | -367.25K | -895.73K | -84.00K | -384.23K | -226.59K | -109.06K | -42.03K | -285.00K | -498.00K | -808.00K | -61.00K |
| Operating income | 1.30M | 1.88M | 540.58K | 1.92M | 6.37M | 4.50M | 2.21M | 1.05M | -4.43M | 7.28M | 7.26M | 2.71M | 1.99M | -6.54M | 11.51M | 10.92M | -131.00K |
| Non-operating income, total | -1.07M | -1.50M | 731.73K | -668.93K | -246.74K | -209.25K | -867.75K | 1.40M | 703.77K | 5.45M | 706.21K | -1.13M | 1.49M | -2.96M | -1.67M | -823.00K | 8.79M |
| Interest expense, net of interest capitalized | -1.15M | -1.08M | -1.16M | -1.46M | -1.31M | -1.88M | -2.61M | -2.05M | -2.01M | -1.32M | -1.46M | -3.21M | -4.66M | -4.37M | -4.36M | -4.63M | -5.30M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 923.49K | 984.90K | 261.09K | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 91.07K | 76.31K | 1.92M | 789.71K | 1.47M | 1.85M | 2.09M | 2.60M | 2.71M | 6.95M | 2.17M | 2.08M | 6.15M | 1.41M | 2.69M | 3.81M | 14.09M |
| Non-operating interest income | 28.81K | 33.51K | 372.40K | 522.55K | 843.18K | 1.34M | 1.21M | 1.59M | 1.17M | 782.45K | 538.24K | 187.80K | 173.18K | 139.00K | 115.00K | 212.00K | 190.00K |
| Miscellaneous non-operating expense | 62.26K | 42.81K | 1.55M | 267.16K | 624.77K | 514.31K | 882.47K | 1.01M | 1.55M | 6.17M | 1.63M | 1.89M | 5.97M | 1.27M | 2.57M | 3.60M | 13.89M |
| Unusual income/expense | -5.78K | -500.02K | -30.49K | — | -401.49K | -178.84K | -350.80K | 856.26K | 0 | -171.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 238.79K | 376.96K | 1.27M | 1.25M | 6.12M | 4.29M | 1.35M | 2.46M | -3.72M | 12.73M | 7.96M | 1.58M | 3.48M | -9.50M | 9.84M | 10.10M | 8.66M |
| Taxes | -86.79K | -138.53K | -447.51K | -362.64K | -2.22M | -1.62M | -501.45K | -790.29K | -750.92K | -2.81M | -2.06M | -1.10M | -1.08M | 2.91M | -2.18M | -2.41M | -2.87M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 152.00K | 238.44K | 824.80K | 884.28K | 3.90M | 2.67M | 844.33K | 1.67M | -4.47M | 9.93M | 5.91M | 479.41K | 2.40M | -6.59M | 7.66M | 7.69M | 5.79M |
| Net income | 152.00K | 238.44K | 824.80K | 884.28K | 3.90M | 2.67M | 844.33K | 1.67M | -4.47M | 9.93M | 5.91M | 479.41K | 2.40M | -6.59M | 7.66M | 7.69M | 5.79M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 152.00K | 238.44K | 824.80K | 884.28K | 3.90M | 2.67M | 844.33K | 1.67M | -4.47M | 9.93M | 5.91M | 479.41K | 2.40M | -6.59M | 7.66M | 7.69M | 5.79M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 4.57M | 5.11M | 3.57M | 4.76M | 9.28M | 7.69M | 7.37M | 5.15M | -345.81K | 10.58M | 10.23M | 9.05M | 14.52M | 4.16M | 19.65M | 22.83M | 12.32M |
| EBIT | 1.30M | 1.88M | 540.58K | 1.92M | 6.37M | 4.50M | 2.21M | 1.05M | -4.43M | 7.28M | 7.26M | 2.71M | 1.99M | -6.54M | 11.51M | 10.92M | -131.00K |
| Total operating expenses | -68.08M | -65.65M | -73.61M | -89.77M | -137.93M | -140.15M | -130.11M | -129.17M | -113.38M | -143.76M | -121.11M | -125.04M | -137.70M | -150.54M | -250.97M | -252.61M | -208.87M |
| Prepaid expenses | 174.53K | 124.39K | 159.83K | — | — | — | — | — | 1.18M | 2.07M | 345.94K | 208.28K | 25.45K | 334.00K | 129.00K | 269.00K | 300.00K |
| Deferred income, current | — | — | — | — | — | — | — | — | 954.40K | 1.75M | 638.29K | 1.56M | 1.03M | 1.88M | 1.28M | 1.77M | 368.00K |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | — | — | — | — | — | — | — | 805.99K | 3.44M | 2.73M | 2.83M | 1.84M | 2.28M |
| Deferred income, non-current | — | — | — | 0 | 0 | 0 | — | 0 | 0 | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800